Ptc Therapeutics (PTCT) Tax Provisions (2015 - 2026)

Ptc Therapeutics' Tax Provisions history runs 12 years deep, the most recent figure standing at $347000.0 for Q1 2026.

• On a quarterly basis, Tax Provisions fell 99.45% year-over-year to $347000.0 in Q1 2026; TTM through Mar 2026 was -$58.5 million, a 170.35% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 83.59% from the prior year.
• Tax Provisions climbed to $347000.0 in Q1 2026 per PTCT's latest filing, from -$13.7 million in the prior quarter.
• Across five years, Tax Provisions topped out at $63.3 million in Q1 2025 and bottomed at -$39.0 million in Q3 2025.
• The 5-year median for Tax Provisions is $3.4 million (2022), against an average of $502352.9.
• Biggest YoY gain for Tax Provisions was 3085.78% in 2022; the steepest drop was 49602.78% in 2022.
• Year by year, Tax Provisions stood at $13.9 million in 2022, then jumped by 195.33% to $41.0 million in 2023, then sank by 105.34% to -$2.2 million in 2024, then tumbled by 525.1% to -$13.7 million in 2025, then surged by 102.53% to $347000.0 in 2026.
• Per Business Quant, the three latest PTCT Tax Provisions figures stand at $347000.0 (Q1 2026), -$13.7 million (Q4 2025), and -$39.0 million (Q3 2025).